Studying Epigenetics of Cardiovascular Diseases on Chip Guide

• Published in: Cardiogenetics 2022-07, Vol.12 (3), p.218-234
• Main Authors: Alghamdi, Bandar, Aljohani, Intisar, Alotaibi, Bandar, Ahmed, Muhammad, Almazmomi, Kholod, Aloufi, Salman, Alshamrani, Jowhra
• Format: Article
• Language: English
• Subjects: Cardiovascular disease; cardiovascular diseases; ChIP-on-chip guide; DNA methylation; Epigenetics; histone modifications; MicroRNAs
• ISSN: 2035-8148; 2035-8253; 2035-8148
• DOI: 10.3390/cardiogenetics12030021

Epigenetics is defined as the study of inheritable changes in the gene expressions and phenotypes that occurs without altering the normal DNA sequence. These changes are mainly due to an alteration in chromatin or its packaging, which changes the DNA accessibility. DNA methylation, histone modification, and noncoding or microRNAs can best explain the mechanism of epigenetics. There are various DNA methylated enzymes, histone-modifying enzymes, and microRNAs involved in the cause of various CVDs (cardiovascular diseases) such as cardiac hypertrophy, heart failure, and hypertension. Moreover, various CVD risk factors such as diabetes mellitus, hypoxia, aging, dyslipidemia, and their epigenetics are also discussed together with CVDs such as CHD (coronary heart disease) and PAH (pulmonary arterial hypertension). Furthermore, different techniques involved in epigenetic chromatin mapping are explained. Among these techniques, the ChIP-on-chip guide is explained with regard to its role in cardiac hypertrophy, a final form of heart failure. This review focuses on different epigenetic factors that are involved in causing cardiovascular diseases.